« Back to Medicines list

HYCAMTIN 1mg and 4mg solution

  • Name:

    HYCAMTIN 1mg and 4mg solution

  • Company:
    info
  • Active Ingredients:

    Topotecan Hydrochloride

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 09/11/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 9/11/2020

Click on this link to Download PDF directly

Novartis Ireland Limited

Novartis Ireland Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Aclasta 5 mg solution for infusion Active Ingredients Zoledronic acid monohydrate
Medicine Name Afinitor Tablets Active Ingredients Everolimus
Medicine Name Aimovig Active Ingredients Erenumab
Medicine Name Atectura Breezhaler Active Ingredients Glycopyrronium bromide, Indacaterol acetate
Medicine Name Atriance 5 mg/ml solution for infusion Active Ingredients Nelarabine
Medicine Name Azarga 10mg/ml + 5mg/ml eye drops, suspension Active Ingredients Brinzolamide, Timolol Maleate
Medicine Name Azopt 10mg/ml eye drops suspension Active Ingredients Brinzolamide
Medicine Name Beovu 120 mg/ml solution for injection in pre-filled syringe Active Ingredients Brolucizumab
Medicine Name Cataflam 50 mg Coated Tablets Active Ingredients Diclofenac Potassium
Medicine Name Certican Tablets Active Ingredients Everolimus
Medicine Name CILOXAN 3 mg/ml ear drops, solution Active Ingredients Ciprofloxacin hydrochloride
Medicine Name Co-Diovan 160 mg/12.5 mg film-coated tablets Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 160mg/25mg film-coated tablets Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 320mg/12.5mg film-coated tablets Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 320mg/25mg film-coated tablets Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 80mg/12.5mg film-coated tablets Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Cosentyx 150 mg solution for injection in pre-filled pen Active Ingredients secukinumab
Medicine Name Desferal 500mg Vials Active Ingredients Desferrioxamine Mesylate
Medicine Name Diovan 160 mg film-coated tablets Active Ingredients Valsartan
Medicine Name Diovan 320mg film-coated tablets Active Ingredients Valsartan
Medicine Name Diovan 3mg/ml Oral Solution Active Ingredients Valsartan
Medicine Name Diovan 40 mg film-coated tablets Active Ingredients Valsartan
Medicine Name Diovan 80 mg film-coated tablets Active Ingredients Valsartan
Medicine Name DuoTrav Eye Drops Solution Active Ingredients Timolol Maleate, Travoprost
Medicine Name Enerzair Breezhaler Active Ingredients Glycopyrronium bromide, Mometasone Furoate, indacaterol acetate
1 - 0 of 118 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 9 November 2020

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Updated on 9 November 2020 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 13 August 2020 PIL

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - manufacturer

Updated on 17 December 2019 PIL

Reasons for updating

  • Improved presentation of PIL

Updated on 28 March 2019

Reasons for updating

  • File format updated to PDF

Updated on 5 November 2018 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation number

Updated on 21 May 2018

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 29 January 2018 PIL

Reasons for updating

  • New PIL for new product

Updated on 29 January 2018 PIL

Reasons for updating

  • Change to section 4 - possible side effects
  • Improved presentation of PIL

Updated on 10 January 2018

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 11 October 2017 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Updated on 25 May 2016 PIL

Reasons for updating

  • Change to marketing authorisation holder

Updated on 16 November 2015 PIL

Reasons for updating

  • Previous version of PIL reinstated

Updated on 6 October 2014 PIL

Reasons for updating

  • Addition of information on reporting a side effect.
  • Change to date of revision
  • Transfer of Marketing Authorisation Holder

Updated on 6 January 2014 PIL

Reasons for updating

  • Change to side-effects

Updated on 30 August 2013 PIL

Reasons for updating

  • Change of distributor details

Updated on 7 February 2011 PIL

Reasons for updating

  • Change to side-effects

Updated on 7 April 2009 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to dosage and administration
  • Change to appearance of the medicine
  • Change to side-effects
  • Change to packaging

Updated on 21 August 2008 PIL

Reasons for updating

  • Change to information about pregnancy or lactation

Updated on 12 June 2008 PIL

Reasons for updating

  • Change to warnings or special precautions for use

Updated on 4 April 2007 PIL

Reasons for updating

  • Change to side-effects

Updated on 4 August 2005 PIL

Reasons for updating

  • Improved electronic presentation

Updated on 28 October 2004 PIL

Reasons for updating

  • New PIL for medicines.ie